Kimera Labs Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms (NCT07664696) | Kimera Labs Inc. | 2027-01-01 |
Track Kimera Labs Inc. automatically
Every clearance here is in the API, with alerts when new ones post.